Interpharm Holdings, Inc.
IPAH
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Revenue | -5.06% | -1.62% | 19.31% | 31.75% | 38.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.06% | -1.62% | 19.31% | 31.75% | 38.12% |
| Cost of Revenue | 10.82% | 15.19% | 17.36% | 23.86% | 31.91% |
| Gross Profit | -43.61% | -38.55% | 24.46% | 53.69% | 55.94% |
| SG&A Expenses | 16.37% | 23.85% | 16.29% | 45.07% | 69.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.32% | 23.77% | 26.62% | 36.52% | 46.44% |
| Operating Income | -214.38% | -1,483.31% | -123.85% | -145.23% | -388.40% |
| Income Before Tax | -142.91% | -979.36% | -152.54% | -208.05% | -467.97% |
| Income Tax Expenses | 360.59% | -76.11% | 111.18% | -122.61% | -362.59% |
| Earnings from Continuing Operations | -355.34% | -1,217.56% | -270.80% | -259.60% | -528.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -355.34% | -1,217.56% | -270.80% | -259.60% | -528.36% |
| EBIT | -214.38% | -1,483.31% | -123.85% | -145.23% | -388.40% |
| EBITDA | -277.24% | -3,931.15% | -157.25% | -263.43% | -4,875.00% |
| EPS Basic | -157.26% | -229.63% | -97.92% | -169.50% | -329.78% |
| Normalized Basic EPS | -98.20% | -351.33% | -35.08% | -35.02% | -165.91% |
| EPS Diluted | -158.21% | -208.14% | -87.88% | -140.52% | -245.38% |
| Normalized Diluted EPS | -95.96% | -263.64% | -22.39% | -18.22% | -116.02% |
| Average Basic Shares Outstanding | 25.14% | 47.06% | 78.50% | 94.83% | 79.28% |
| Average Diluted Shares Outstanding | 23.31% | 21.12% | 45.68% | 54.14% | 40.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.00% | 0.96% | 0.87% | 0.65% | 0.80% |